Live news , top stories, corporate news, company news, sector news, economy news, results analysis news, ceo interviews, fund manager interview, advisor interview, market news, bazaar talk, hot stocks news, ipo news, commodities news, mutual fund news, insurance news, news wire
29 November, 2014 00:32 IST
Aurobindo gains on USFDA approval for Oxacillin
Source: IRIS | 21 Jan, 2013, 11.47AM
Comments  |  Post Comment

Aurobindo Pharma, a mid-size pharmaceutical company, gained on Monday after it has received final approvals from the US Food & Drug Administration (USFDA) to manufacture and market Oxacillin for Injection USP, packaged in 1g and 2g vials and Oxacillin for Injection USP 10g/Vial pharmacy bulk package.

Oxacillin for Injection USP is a sterile semisynthetic penicillin (SSP) indicated in the treatment of infections caused by penicillinase producing staphylococci which have demonstrated susceptibility to the drug.

Shares of the company are trading at Rs 195.70, up Rs 3.1, or 1.61% at the Bombay Stock Exchange (BSE) on Monday at 11:42 a.m.

The scrip has touched an intra-day high of Rs 196.70 and low of Rs 193.10. The total volume of shares traded at the BSE is 105,697.

In the earlier session, the shares gained 2.15%, or Rs 4.05, at Rs 192.60. Currently, the stock is trading down 4.49% from its 52-week high of Rs 204.90 and above 104.81% over the 52-week low of Rs 95.55.



Share Price Movement
Period Price
in Rs
Gain/(Loss)
in Rs in %
1 Week 184.55 8.05 4.36
1 Month 195.10 (2.50) (1.28)
3 Months 156.80 35.80 22.83
6 Months 108.40 84.20 77.68
1 Year 100.10 92.50 92.41
Note: Based on previous day closing price.


Aurobindo Pharma Limited   (Q,N,C,F)*


Related Articles
Ind-Ra rates Prism Cement's Rs 1,000 mn NCDs at 'A-' - 28-Nov-2014 17:36
IDBI Bank opens Zonal Office in Chandigarh - 28-Nov-2014 16:22
CRISIL reaffirms `AA+/Stable/A1+` on Bharti Airtel - 28-Nov-2014 15:02
State Bank of India shares climb on partnership with Nissan - 28-Nov-2014 14:51
Nissan, SBI enter strategic tie-up to offer vehicle finance options in India - 28-Nov-2014 14:48
ICICI Bank allots 227,650 shares under ESOS - 28-Nov-2014 14:27
Coal India gives nod for MCL project worth Rs 113.63 bn - 28-Nov-2014 14:15
GEPL Capital maintains 'Buy' on VIP Industries; target Rs 123 - 28-Nov-2014 11:34
Ind-Ra affirms Coromandel International at 'AA+' - 28-Nov-2014 10:12
'Accumulate' Tata Steel; target of Rs 530: Prabhudas Lilladher - 27-Nov-2014 18:22
Essar Steel commissions 6 mtpa pellet complex in Odisha - 27-Nov-2014 18:08
more...
* Q - Quote , N - News , C - Chart , F - Financials
Comments Post comment 
 Post Comment
Name Email
Comment
Security Code type    into this box
Home  |   Shares  |   F&O  |   Mutual Funds  |   Loans  |   Insurance  |   News Centre
Wealth Tracker  |   Newsletters  |   Tax Corner  |   NRI Centre  |   Advertise
© All rights reserved. IRIS Business Services Limited
A Disclaimer